Fund Holdings — RA CAPITAL MANAGEMENT, L.P.

Total Portfolio Value
$5.94B
Total Bought
$370.64M
Total Sold
$659.69M
Net Transaction
-$289.05M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ASCENDIS PHARMA A/S - ADR(ASND)10,281,49610,281,49601,602,4741,774,58629.90%+172,112
CIDARA THERAPEUTICS INC1,092,7963,365,523+2,272,72723,539163,9352.76%+140,396
SIONNA THERAPEUTICS INC(SION)10,445,32210,445,3220109,258181,2263.05%+71,968
ARS PHARMACEUTICALS INC(SPRY)10,860,97710,860,9770136,631189,5243.19%+52,893
89BIO INC19,889,68319,889,6830144,598195,3173.29%+50,719
FULCRUM THERAPEUTICS INC(FULC)10,229,09910,229,099029,46070,3761.19%+40,916
TAYSHA GENE THERAPIES INC(TSHA)10,872,50323,555,648+12,683,14515,11354,4140.92%+39,301
VOR BIOPHARMA INC(VOR)39,646,03939,646,039028,44664,2271.08%+35,781
SEPTERNA INC(SEPN)6,995,8586,995,858040,50673,9461.25%+33,440
RHYTHM PHARMACEUTICALS INC(RYTM)6,084,4125,561,359-523,053322,291351,4225.92%+29,131
AVIDITY BIOSCIENCES INC6,300,4087,266,031+965,623185,988206,3553.48%+20,367
TYRA BIOSCIENCES INC(TYRA)10,637,29012,198,625+1,561,33598,927116,7411.97%+17,814
GH RESEARCH PLC(GHRS)6,944,6487,676,697+732,04976,59993,5791.58%+16,979
HINGE HEALTH INC-A(HNGE)0300,000+300,000015,5250.26%+15,525
LENZ THERAPEUTICS INC(LENZ)4,178,8234,178,8230107,438122,4812.06%+15,044
SOLID BIOSCIENCES INC4,330,4465,811,323+1,480,87716,02328,3010.48%+12,278
JADE BIOSCIENCES INC01,062,326+1,062,326010,6130.18%+10,613
TANGO THERAPEUTICS INC(TNGX)02,000,000+2,000,000010,2400.17%+10,240
OMADA HEALTH INC(OMDA)0400,000+400,00007,3200.12%+7,320
CYTOMX THERAPEUTICS INC(CTMX)1,000,0002,661,331+1,661,3316366,0410.10%+5,405
GENEDX HOLDINGS CORP(WGS)058,044+58,04405,3580.09%+5,358
DISC MEDICINE INC(IRON)1,577,1061,577,106078,28883,5241.41%+5,236
STRUCTURE THERAPEUTICS INC1,517,4181,517,418026,26731,4710.53%+5,205
LARIMAR THERAPEUTICS INC(LRMR)6,045,3516,045,351012,99817,4710.29%+4,474
SCHOLAR ROCK HOLDING CORP(SRRK)1,136,4531,136,453036,53740,2530.68%+3,716
4D MOLECULAR THERAPEUTICS IN4,563,2114,563,211014,73916,9300.29%+2,190
TOURMALINE BIO INC2,538,9252,538,925038,61740,5970.68%+1,980
INFLARX NV(IFRX)01,973,233+1,973,23301,5590.03%+1,559
DIANTHUS THERAPEUTICS INC(DNTH)2,866,7332,866,733052,00353,4070.90%+1,405
WEREWOLF THERAPEUTICS INC(HOWL)6,144,8816,681,307+536,4265,9747,2830.12%+1,309
BETA BIONICS INC(BBNX)500,000500,00006,1207,2800.12%+1,160
ACUMEN PHARMACEUTICALS INC(ABOS)14,932,06314,932,063016,42517,3210.29%+896
METSERA INC675,525675,525018,38819,2190.32%+831
ARCELLX INC
COMMON STOCK
3,036,5273,036,5270199,196199,9553.37%+759
CLIMB BIO INC(CLYM)31,419,26731,419,267038,33238,9600.66%+628
ARCUS BIOSCIENCES INC(RCUS)1,136,3641,136,36408,9209,2500.16%+330
ENLIVEN THERAPEUTICS INC848,986848,986016,70817,0310.29%+323
PERCEPTIVE CAPITAL SOLUTIONS
CL A ORD SHS
750,000750,00007,7257,9650.13%+240
SCILEX HOLDING CO(SCLX)1,036,2180-1,036,2182580—-257
MONOPAR THERAPEUTICS INC(MNPR)511,207511,207018,61318,2910.31%-322
NEWAMSTERDAM PHARMA CO NV-27
*W EXP 99/99/999
333,333333,33302,9972,6670.04%-330
ADICET BIO INC7,541,0007,541,00005,6934,6000.08%-1,093
LEXEO THERAPEUTICS INC(LXEO)546,5540-546,5541,8970—-1,897
NKARTA INC(NKTX)10,805,12910,805,129019,88117,9370.30%-1,945
ELEDON PHARMACEUTICALS INC(ELDN)3,566,3383,566,338012,0909,6650.16%-2,425
SURROZEN INC(SRZN)679,130602,626-76,5047,9195,3870.09%-2,531
SUTRO BIOPHARMA INC(STRO)4,434,6370-4,434,6372,8850—-2,885
AVALO THERAPEUTICS INC(AVTX)967,000932,973-34,0277,7464,6560.08%-3,090
PEPGEN INC(PEPG)10,689,54510,689,545015,01911,8650.20%-3,153
BOUNDLESS BIO INC(BOLD)2,180,6310-2,180,6313,2930—-3,293
TRAVERE THERAPEUTICS INC(TVTX)1,150,0001,150,000020,60817,0200.29%-3,588
BIOAGE LABS INC(BIOA)1,052,4940-1,052,4943,9570—-3,957
ZURA BIO LTD(ZURA)3,217,5030-3,217,5034,1510—-4,151
ACADIA HEALTHCARE CO INC(ACHC)217,00089,262-127,7386,5792,0250.03%-4,554
HUMACYTE INC(HUMA)3,312,3560-3,312,3565,6480—-5,648
XENCOR INC(XNCR)575,0000-575,0006,1180—-6,118
MBX BIOSCIENCES INC(MBX)1,511,334377,841-1,133,49311,1544,3110.07%-6,842
ACRIVON THERAPEUTICS INC8,340,5088,340,508016,9319,9250.17%-7,006
ACLARIS THERAPEUTICS INC(ACRS)4,666,6670-4,666,6677,1400—-7,140
Bright Minds Biosciences Inc(DRUG)206,4270-206,4277,4460—-7,446
IMMATICS NV(IMTX)1,750,0000-1,750,0007,8930—-7,892
DYNE THERAPEUTICS INC(DYN)9,714,3929,714,3920101,61392,4811.56%-9,132
BICYCLE THERAPEUTICS PLC-ADR1,093,4770-1,093,4779,2840—-9,284
GERON CORP(GERN)60,379,36660,379,366096,00385,1351.43%-10,868
SERA PROGNOSTICS INC-A(SERA)3,032,8080-3,032,80811,1610—-11,161
PROTARA THERAPEUTIC INC(TARA)3,400,0001,039,295-2,360,70514,4843,1490.05%-11,335
10X GENOMICS INC-CLASS A(TXG)1,944,247475,343-1,468,90416,9735,5040.09%-11,469
ALECTOR INC9,695,2280-9,695,22811,9250—-11,925
MINERALYS THERAPEUTICS INC(MLYS)6,147,2806,147,280097,61983,1731.40%-14,446
ARTIVA BIOTHERAPEUTICS INC(ARTV)9,853,3029,853,302029,56014,8780.25%-14,681
INSMED INC(INSM)200,0000-200,00015,2580—-15,258
NURIX THERAPEUTICS INC(NRIX)1,333,3330-1,333,33315,8400—-15,840
CERIBELL INC(CBLL)824,5820-824,58215,8400—-15,840
EYEPOINT PHARMACEUTICALS INC(EYPT)3,181,8180-3,181,81817,2450—-17,245
GLAUKOS CORP(GKOS)190,2560-190,25618,7250—-18,725
ITEOS THERAPEUTICS INC3,649,0570-3,649,05721,7850—-21,785
IDEAYA BIOSCIENCES INC(IDYA)1,347,2520-1,347,25222,0680—-22,068
AEROVATE THERAPEUTICS INC9,192,0920-9,192,09223,0720—-23,072
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
10,138,93810,138,9380207,544183,6163.09%-23,928
BICARA THERAPEUTICS INC6,955,9936,955,993090,63764,6211.09%-26,015
KURA ONCOLOGY INC(KURA)4,004,6100-4,004,61026,4300—-26,430
ASTRIA THERAPEUTICS INC5,105,2130-5,105,21327,2620—-27,262
WAVE LIFE SCIENCES LTD(WVE)18,202,00918,202,0090147,072118,3131.99%-28,759
UROGEN PHARMA LTD(URGN)3,206,2710-3,206,27135,4610—-35,461
JANUX THERAPEUTICS INC(JANX)11,189,69311,189,6930302,122258,4824.35%-43,640
DAY ONE BIOPHARMACEUTICALS I
COM
5,755,5770-5,755,57745,6420—-45,642
RXSIGHT INC(RXST)3,743,0183,702,967-40,05194,51148,1390.81%-46,373
ZAI LAB LTD-ADR(ZLAB)1,295,0400-1,295,04046,8030—-46,803
APOGEE THERAPEUTICS INC(APGE)1,569,4910-1,569,49158,6360—-58,636
EDGEWISE THERAPEUTICS INC(EWTX)8,909,0919,902,633+993,542196,000129,8242.19%-66,176
VAXCYTE INC(PCVX)12,189,14911,965,991-223,158460,262389,0146.55%-71,248
Page 1 of 1
RA CAPITAL MANAGEMENT, L.P. — 13F Holdings — Q2 2025 | TickerTrail